The COVID-19 discard tests and other collateral services have been the great support and refuge of many laboratories, after the medical care and analysis of chronic diseases, among others not associated with this virus, were interrupted in 2020 and also at the beginning of this 2021.
Thus, companies like Suiza Lab –Which has clinical laboratories, medical centers, ambulance and hospital care, emergency, pharmacy, genetic tests and dentistry– have been able to overcome the temporary illness and even register significant growth, which will lead it to end the year with sales of S / 100 million, 30% more than in 2020, he says Sergio Orellana, your administrative manager.
This advance and the comprehensive automation of sample processing and management – which allows greater efficiency in volume, time and in achieving more competitive prices – will support the company’s expansion plan that aims to more than double its coverage in the country over the next two years , going from 12 locations to 26 (22 laboratories and 4 medical centers).
To date, they have 9 offices in Lima (two medical centers) and three in the cities of Chiclayo, Piura and Tarapoto, and this year they will add four more in Arequipa, Tarapoto (medical center), Comas and Callao. These last two, to be inaugurated between the end of September and November, will be part of the Mall Plaza Comas and Bellavista shopping centers, respectively, although they will be out of traffic since they will have independent income.
Focus on provinces
Meanwhile, by 2022 the objective is to land in Trujillo (first quarter) and they are evaluating proposals in Tacna, Iquitos, Huancayo and Ica; they also plan to move to a larger location in Piura. “Our project is to have a branch in the main cities of the country by 2024,” says Orellana.
It specifies that, depending on the size of the laboratories, these will require an investment between US $ 120,000 and US $ 200,000.
But, the biggest bet of Suiza Lab – which celebrates 25 years of operations in the country – will take place in Lima (Av. Primavera, Santiago de Surco) also next year, since They will begin the construction of an eight-story flagship medical center, which will have all the specialties (cardiology, dermatology, gastroenterology, endocrinology and dentistry, which are already covered in their centers) and will implement the resonance and tomography services. “This will require a total investment of US $ 5 million, approximately, considering the construction, implementation and equipment, it will be ready in 2023. We are going to see how the economic and political situation moves,” he says.
The executive points out that they have also acquired artificial intelligence software that gives them more prediction regarding patient care. “We are moving to the next level in care and infrastructure,” he notes.
In addition, they have enabled a fully automated contact center, through an agreement with Amazon and Zendesk in order to offer an integrated customer service service. “We do this with a high-tech CRM platform, where all our social networks and communication channels are integrated,” he explains.
On the other hand, he points out that medicine has become more expensive due to the use of implementation associated with care (personal protective equipment, PPE, among others). He estimates that the costs of specialty doctor visits have increased 100% since last year. While, general medicine care increased between 30% and 40%.
These costs are unlikely to go down because protocols must be maintained, Orellana says.
The company, which at the time was questioned for not being authorized to carry out molecular detection tests for COVID-19, hopes by the end of the month to have the approval by the National Institute for it. Finally, it reveals that they are also in the process of bringing other evidence also linked to the pandemic.